We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Are Medical Stocks Lagging Elevance Health, Inc. (ELV) This Year?
Read MoreHide Full Article
Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. Has Elevance Health (ELV - Free Report) been one of those stocks this year? Let's take a closer look at the stock's year-to-date performance to find out.
Elevance Health is one of 917 companies in the Medical group. The Medical group currently sits at #10 within the Zacks Sector Rank. The Zacks Sector Rank considers 16 different sector groups. The average Zacks Rank of the individual stocks within the groups is measured, and the sectors are listed from best to worst.
The Zacks Rank is a successful stock-picking model that emphasizes earnings estimates and estimate revisions. The system highlights a number of different stocks that could be poised to outperform the broader market over the next one to three months. Elevance Health is currently sporting a Zacks Rank of #2 (Buy).
Within the past quarter, the Zacks Consensus Estimate for ELV's full-year earnings has moved 1.1% higher. This signals that analyst sentiment is improving and the stock's earnings outlook is more positive.
According to our latest data, ELV has moved about 8.9% on a year-to-date basis. Meanwhile, stocks in the Medical group have gained about 0.2% on average. This means that Elevance Health is performing better than its sector in terms of year-to-date returns.
Another Medical stock, which has outperformed the sector so far this year, is American Well Corporation (AMWL - Free Report) . The stock has returned 161.1% year-to-date.
For American Well Corporation, the consensus EPS estimate for the current year has increased 4.5% over the past three months. The stock currently has a Zacks Rank #2 (Buy).
Looking more specifically, Elevance Health belongs to the Medical Services industry, which includes 70 individual stocks and currently sits at #95 in the Zacks Industry Rank. On average, stocks in this group have gained 1.5% this year, meaning that ELV is performing better in terms of year-to-date returns.
On the other hand, American Well Corporation belongs to the Medical Info Systems industry. This 41-stock industry is currently ranked #87. The industry has moved +19% year to date.
Investors with an interest in Medical stocks should continue to track Elevance Health and American Well Corporation. These stocks will be looking to continue their solid performance.
View the Zacks #1 Rank List
Image: Bigstock
Are Medical Stocks Lagging Elevance Health, Inc. (ELV) This Year?
Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. Has Elevance Health (ELV - Free Report) been one of those stocks this year? Let's take a closer look at the stock's year-to-date performance to find out.
Elevance Health is one of 917 companies in the Medical group. The Medical group currently sits at #10 within the Zacks Sector Rank. The Zacks Sector Rank considers 16 different sector groups. The average Zacks Rank of the individual stocks within the groups is measured, and the sectors are listed from best to worst.
The Zacks Rank is a successful stock-picking model that emphasizes earnings estimates and estimate revisions. The system highlights a number of different stocks that could be poised to outperform the broader market over the next one to three months. Elevance Health is currently sporting a Zacks Rank of #2 (Buy).
Within the past quarter, the Zacks Consensus Estimate for ELV's full-year earnings has moved 1.1% higher. This signals that analyst sentiment is improving and the stock's earnings outlook is more positive.
According to our latest data, ELV has moved about 8.9% on a year-to-date basis. Meanwhile, stocks in the Medical group have gained about 0.2% on average. This means that Elevance Health is performing better than its sector in terms of year-to-date returns.
Another Medical stock, which has outperformed the sector so far this year, is American Well Corporation (AMWL - Free Report) . The stock has returned 161.1% year-to-date.
For American Well Corporation, the consensus EPS estimate for the current year has increased 4.5% over the past three months. The stock currently has a Zacks Rank #2 (Buy).
Looking more specifically, Elevance Health belongs to the Medical Services industry, which includes 70 individual stocks and currently sits at #95 in the Zacks Industry Rank. On average, stocks in this group have gained 1.5% this year, meaning that ELV is performing better in terms of year-to-date returns.
On the other hand, American Well Corporation belongs to the Medical Info Systems industry. This 41-stock industry is currently ranked #87. The industry has moved +19% year to date.
Investors with an interest in Medical stocks should continue to track Elevance Health and American Well Corporation. These stocks will be looking to continue their solid performance.